Skip to main content
. 2018 Aug 31;21(11):1506–1516. doi: 10.1093/ntr/nty184

Table 5.

Combined Results From Treatment Groups for Secondary Outcomes by Time Point

Mean 95% CI p Value
Cigarette dependency (n = 345)
 Baseline 4.24 (3.99 to 4.50) reference
 1 mo 1.54 (1.27 to 1.81) <.0001
 3 mo 2.06 (1.78 to 2.34) <.0001
 6 mo 1.89 (1.63 to 2.16) <.0001
 12 mo 2.07 (1.77 to 2.37) <.0001
Average cigarettes per day (n = 345)
 Baseline 12.90 (12.07 to 13.73) reference
 1 mo 2.66 (2.20 to 3.12) <.0001
 3 mo 4.56 (3.91 to 5.20) <.0001
 6 mo 5.59 (4.82 to 6.36) <.0001
 12 mo 6.54 (5.57 to 7.52) <.0001
Smoking urges (n = 345)
 Baseline 36.26 (34.85 to 37.67) reference
 1 mo 18.55 (17.11 to 19.99) <.0001
 3 mo 20.55 (19.01 to 22.09) <.0001
 6 mo 22.25 (20.48 to 24.03) <.0001
 12 mo 22.27 (20.42 to 24.12) <.0001
Nicotine withdrawal (n = 345)
 Baseline 12.63 (11.84 to 13.42) reference
 1 mo 6.85 (6.03 to 7.67) <.0001
 3 mo 7.30 (6.44 to 8.17) <.0001
 6 mo 8.64 (7.72 to 9.55) <.0001
 12 mo 9.17 (8.19 to 10.15) <.0001
Readiness to quit (n = 345)
 Baseline 6.92 (6.80 to 7.04) reference
 1 mo 8.37 (8.18 to 8.55) <.0001
 3 mo 8.06 (7.87 to 8.25) <.0001
 6 mo 7.87 (7.68 to 8.07) <.0001
 12 mo 7.69 (7.47 to 7.92) <.0001
Abstinence self-efficacy (n = 345)
 Baseline 18.58 (17.56 to 19.61) reference
 1 mo 29.16 (27.96 to 30.36) <.0001
 3 mo 23.88 (22.60 to 25.16) <.0001
Perceived risks of quittinga (n = 140)
 Baseline 3.97 (3.81 to 4.13) reference
 1 mo 3.21 (2.97 to 3.44) <.0001
 3 mo 3.21 (2.99 to 3.43) <.0001
Perceived Benefits of Quittinga (n = 140)
 Baseline 6.16 (6.01 to 6.31) reference
 1 mo 6.09 (5.91 to 6.28) .070
 3 mo 6.07 (5.87 to 6.27) .071
Weight gain concernsa (n = 140)
 Baseline 11.84 (11.12 to 12.56) reference
 1 mo 10.03 (9.11 to 10.95) <.0001
 3 mo 10.17 (9.27 to 11.08) <.0001

CI = confidence interval.

aQuestionnaire only administered to current smokers. Model only includes participants who were smoking at the 3 mo time point. Results are unadjusted.